• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam2Cys

tetano

Editor, Senior Moderator
Immunol Cell Biol. 2015 Aug 14. doi: 10.1038/icb.2015.81. [Epub ahead of print]
[h=1]Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam2Cys.[/h] Mifsud EJ[SUP]1[/SUP], Tan AC[SUP]1[/SUP], Reading PC[SUP]2[/SUP], Jackson DC[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] We have previously shown that intranasal administration of the Toll-like receptor-2 (TLR-2) agonist, S-[2,3-bis(palmitoyloxy)propyl] cysteine (Pam[SUB]2[/SUB]Cys), provides immediate and antigen independent protection against challenge with influenza virus. Here we characterize the cellular pulmonary environments of mice which had either been treated with Pam[SUB]2[/SUB]Cys or placebo and then challenged with influenza virus. We show that Pam[SUB]2[/SUB]Cys treatment results in the influx of innate immune cells into the lungs and that depletion of phagocytic cells from this influx using clodronate-loaded liposomes caused a reduction in the number of interstitial macrophages and monocytes. This resulted in abolition of the protective effect indicating the importance of this cellular subset in Pam[SUB]2[/SUB]Cys-mediated protection.Immunology and Cell Biology accepted article preview online, 14 August 2015. doi:10.1038/icb.2015.81.


PMID: 26272554 [PubMed - as supplied by publisher]
 
Back
Top Bottom